|Study Type:||Phase I|
|Stage:||Follow up complete|
|Study Start Date:||NA|
|Study Made Public:||NA|
A Phase 1 double blind placebo-controlled clinical trial to evaluate the safety and to compare the priming ability of NYVAC alone versus NYVAC + AIDSVAX B/E, and DNA alone versus DNA + AIDSVAX B/E when followed by NYVAC + AIDSVAX B/E boosts in healthy, HIV-1 uninfected adult participants
HVTN 096 (EV04) is a Phase I clinical trial to evaluate the safety and immunogenicity of prime/boost regimens using combinations of DNA-HIV-PT123, NYVAC-HIV-PT1, NYVAC-HIV-PT4, and AIDSVAX B/E.
Sign in to see full information about this study and to download study data.
ProductsProduct info coming soon!
No integrated data is available for this study.
No non-integrated data is available for this study.